Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2010

Open Access 01-12-2010 | Original investigation

The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome

Authors: Arie Steinvil, Itzhak Shapira, Orit Kliuk Ben-Bassat, Michael Cohen, Yaffa Vered, Shlomo Berliner, Ori Rogowski

Published in: Cardiovascular Diabetology | Issue 1/2010

Login to get access

Abstract

Background

Metabolic syndrome (MetS) is frequently characterized by elevated liver enzymes, including gamma-glutamyl transferase (GGT) and alanine aminotransferase (ALT). Our objective was to evaluate the range of prevalence of MetS in apparently healthy individuals whose liver enzyme concentrations were all within-normal-range.

Methods

We have performed a cross sectional analysis on participants of the Tel-Aviv medical center inflammation survey (TAMCIS) recruited between the years 2003-2009. Analyzed were a cohort of 6,561 men and 3,389 women.

Results

The prevalence of MetS increased significantly from the first quintile to the fifth for both GGT and ALT, all the five quintiles being in the normal range. Logistic regression analysis for the presence of MetS showed crude odds ratios of 2.7 and 2.4 between the first and fourth quintiles and 3.6 and 3.2 for the fifth quintile in men and women respectively for ALT. For GGT the respective odds being 3.6 and 3.2 for the fourth quintile and 3.9 and 3.4 for the fifth quintile in men and women, respectively.

Conclusions

A relatively high prevalence of MetS was noted in a cohort of apparently healthy individuals with liver enzyme concentrations within-normal-limits. Practical consequences include the need to follow up these enzyme concentrations as continuous variables and to take into consideration that even relatively small elevations within the normal range might reflect the presence of dysmetabolism.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005, 112: 666-673. 10.1161/CIRCULATIONAHA.104.516948.CrossRefPubMed Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005, 112: 666-673. 10.1161/CIRCULATIONAHA.104.516948.CrossRefPubMed
2.
go back to reference Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S: Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007, 49: 2112-2119. 10.1016/j.jacc.2007.01.088.CrossRefPubMed Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S: Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007, 49: 2112-2119. 10.1016/j.jacc.2007.01.088.CrossRefPubMed
3.
go back to reference Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama. 2002, 288: 2709-2716. 10.1001/jama.288.21.2709.CrossRefPubMed Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama. 2002, 288: 2709-2716. 10.1001/jama.288.21.2709.CrossRefPubMed
4.
go back to reference Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004, 110: 1245-1250. 10.1161/01.CIR.0000140677.20606.0E.CrossRefPubMed Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004, 110: 1245-1250. 10.1161/01.CIR.0000140677.20606.0E.CrossRefPubMed
5.
go back to reference Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D: Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Diabet Med. 2008, 25: 523-529. 10.1111/j.1464-5491.2008.02408.x.CrossRefPubMed Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D: Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Diabet Med. 2008, 25: 523-529. 10.1111/j.1464-5491.2008.02408.x.CrossRefPubMed
6.
go back to reference Andre P, Balkau B, Vol S, Charles MA, Eschwege E: Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care. 2007, 30: 2355-2361. 10.2337/dc07-0440.CrossRefPubMed Andre P, Balkau B, Vol S, Charles MA, Eschwege E: Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care. 2007, 30: 2355-2361. 10.2337/dc07-0440.CrossRefPubMed
7.
go back to reference Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E: Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care. 2005, 28: 1757-1762. 10.2337/diacare.28.7.1757.CrossRefPubMed Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E: Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care. 2005, 28: 1757-1762. 10.2337/diacare.28.7.1757.CrossRefPubMed
8.
go back to reference Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Haffner SM: Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes. 2005, 54: 3140-3147. 10.2337/diabetes.54.11.3140.CrossRefPubMed Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Haffner SM: Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes. 2005, 54: 3140-3147. 10.2337/diabetes.54.11.3140.CrossRefPubMed
9.
go back to reference Liangpunsakul S, Chalasani N: Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III). Am J Med Sci. 2005, 329: 111-116. 10.1097/00000441-200503000-00001.CrossRefPubMed Liangpunsakul S, Chalasani N: Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III). Am J Med Sci. 2005, 329: 111-116. 10.1097/00000441-200503000-00001.CrossRefPubMed
10.
go back to reference Goessling W, Massaro JM, Vasan RS, D'Agostino RB, Ellison RC, Fox CS: Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease. Gastroenterology. 2008, 135 (6): 1935-44. 10.1053/j.gastro.2008.09.018. 1944.ePubMedCentralCrossRefPubMed Goessling W, Massaro JM, Vasan RS, D'Agostino RB, Ellison RC, Fox CS: Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease. Gastroenterology. 2008, 135 (6): 1935-44. 10.1053/j.gastro.2008.09.018. 1944.ePubMedCentralCrossRefPubMed
11.
go back to reference Emdin M, Passino C, Michelassi C, Titta F, L'Abbate A, Donato L, Pompella A, Paolicchi A: Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J. 2001, 22: 1802-1807. 10.1053/euhj.2001.2807.CrossRefPubMed Emdin M, Passino C, Michelassi C, Titta F, L'Abbate A, Donato L, Pompella A, Paolicchi A: Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J. 2001, 22: 1802-1807. 10.1053/euhj.2001.2807.CrossRefPubMed
12.
go back to reference Jousilahti P, Rastenyte D, Tuomilehto J: Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke. 2000, 31: 1851-1855.CrossRefPubMed Jousilahti P, Rastenyte D, Tuomilehto J: Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke. 2000, 31: 1851-1855.CrossRefPubMed
13.
go back to reference Lee DH, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, Tuomilehto J: Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J. 2006, 27: 2170-2176. 10.1093/eurheartj/ehl086.CrossRefPubMed Lee DH, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, Tuomilehto J: Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J. 2006, 27: 2170-2176. 10.1093/eurheartj/ehl086.CrossRefPubMed
14.
go back to reference Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS: Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007, 27: 127-133. 10.1161/01.ATV.0000251993.20372.40.CrossRefPubMed Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS: Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007, 27: 127-133. 10.1161/01.ATV.0000251993.20372.40.CrossRefPubMed
15.
go back to reference Meisinger C, Doring A, Schneider A, Lowel H: Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis. 2006, 189: 297-302. 10.1016/j.atherosclerosis.2006.01.010.CrossRefPubMed Meisinger C, Doring A, Schneider A, Lowel H: Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis. 2006, 189: 297-302. 10.1016/j.atherosclerosis.2006.01.010.CrossRefPubMed
16.
go back to reference Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H: Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005, 112: 2130-2137. 10.1161/CIRCULATIONAHA.105.552547.CrossRefPubMed Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H: Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005, 112: 2130-2137. 10.1161/CIRCULATIONAHA.105.552547.CrossRefPubMed
17.
go back to reference Wannamethee G, Ebrahim S, Shaper AG: Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol. 1995, 142: 699-708.PubMed Wannamethee G, Ebrahim S, Shaper AG: Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol. 1995, 142: 699-708.PubMed
18.
go back to reference Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M: gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk. Medical hypotheses. 2006, 67: 1060-1064. 10.1016/j.mehy.2006.04.010.CrossRefPubMed Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M: gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk. Medical hypotheses. 2006, 67: 1060-1064. 10.1016/j.mehy.2006.04.010.CrossRefPubMed
19.
go back to reference Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA: Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care. 2009, 32: 741-750. 10.2337/dc08-1870.PubMedCentralCrossRefPubMed Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA: Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care. 2009, 32: 741-750. 10.2337/dc08-1870.PubMedCentralCrossRefPubMed
20.
go back to reference Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S: Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006, 44: 865-873. 10.1002/hep.21327.CrossRefPubMed Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S: Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006, 44: 865-873. 10.1002/hep.21327.CrossRefPubMed
21.
go back to reference Kain K, Carter AM, Grant PJ, Scott EM: Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population. J Thromb Haemost. 2008, 6: 737-741. 10.1111/j.1538-7836.2008.02935.x.CrossRefPubMed Kain K, Carter AM, Grant PJ, Scott EM: Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population. J Thromb Haemost. 2008, 6: 737-741. 10.1111/j.1538-7836.2008.02935.x.CrossRefPubMed
22.
go back to reference Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes. 2004, 53: 2855-2860. 10.2337/diabetes.53.11.2855.CrossRefPubMed Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes. 2004, 53: 2855-2860. 10.2337/diabetes.53.11.2855.CrossRefPubMed
23.
go back to reference Steinvil A, Berliner S, Bromberg M, Cohen M, Shalev V, Shapira I, Rogowski O: Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: potential triggers for atherothrombotic events. Atherosclerosis. 2009, 206: 270-275. 10.1016/j.atherosclerosis.2009.01.045.CrossRefPubMed Steinvil A, Berliner S, Bromberg M, Cohen M, Shalev V, Shapira I, Rogowski O: Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: potential triggers for atherothrombotic events. Atherosclerosis. 2009, 206: 270-275. 10.1016/j.atherosclerosis.2009.01.045.CrossRefPubMed
24.
go back to reference Rogowski O, Steinvil A, Berliner S, Cohen M, Saar N, Ben-Bassat OK, Shapira I: Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol. 2009, 8: 55-10.1186/1475-2840-8-55.PubMedCentralCrossRefPubMed Rogowski O, Steinvil A, Berliner S, Cohen M, Saar N, Ben-Bassat OK, Shapira I: Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol. 2009, 8: 55-10.1186/1475-2840-8-55.PubMedCentralCrossRefPubMed
25.
go back to reference Rogowski O, Shapira I, Steinvil A, Berliner S: Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Metabolism. 2009, 58: 661-667. 10.1016/j.metabol.2009.01.005.CrossRefPubMed Rogowski O, Shapira I, Steinvil A, Berliner S: Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Metabolism. 2009, 58: 661-667. 10.1016/j.metabol.2009.01.005.CrossRefPubMed
26.
go back to reference Rogowski O, Shapira I, Peretz H, Berliner S: Glycohaemoglobin as a determinant of increased fibrinogen concentrations and low-grade inflammation in apparently healthy nondiabetic individuals. Clin Endocrinol (Oxf). 2008, 68: 182-189. Rogowski O, Shapira I, Peretz H, Berliner S: Glycohaemoglobin as a determinant of increased fibrinogen concentrations and low-grade inflammation in apparently healthy nondiabetic individuals. Clin Endocrinol (Oxf). 2008, 68: 182-189.
27.
go back to reference Rogowski O, Shapira I, Shirom A, Melamed S, Toker S, Berliner S: Heart rate and microinflammation in men: a relevant atherothrombotic link. Heart. 2007, 93: 940-944. 10.1136/hrt.2006.101949.PubMedCentralCrossRefPubMed Rogowski O, Shapira I, Shirom A, Melamed S, Toker S, Berliner S: Heart rate and microinflammation in men: a relevant atherothrombotic link. Heart. 2007, 93: 940-944. 10.1136/hrt.2006.101949.PubMedCentralCrossRefPubMed
28.
go back to reference Rogowski O, Toker S, Shapira I, Melamed S, Shirom A, Zeltser D, Berliner S: Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol. 2005, 95: 152-155. 10.1016/j.amjcard.2004.08.086.CrossRefPubMed Rogowski O, Toker S, Shapira I, Melamed S, Shirom A, Zeltser D, Berliner S: Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol. 2005, 95: 152-155. 10.1016/j.amjcard.2004.08.086.CrossRefPubMed
29.
go back to reference Steinvil A, Shirom A, Melamed S, Toker S, Justo D, Saar N, Shapira I, Berliner S, Rogowski O: Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol. 2008, 102: 1034-1039. 10.1016/j.amjcard.2008.05.055.CrossRefPubMed Steinvil A, Shirom A, Melamed S, Toker S, Justo D, Saar N, Shapira I, Berliner S, Rogowski O: Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol. 2008, 102: 1034-1039. 10.1016/j.amjcard.2008.05.055.CrossRefPubMed
30.
go back to reference Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.
31.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
32.
go back to reference Barham D, Trinder P: An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst. 1972, 97: 142-145. 10.1039/an9729700142.CrossRefPubMed Barham D, Trinder P: An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst. 1972, 97: 142-145. 10.1039/an9729700142.CrossRefPubMed
33.
go back to reference Fossati P, Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982, 28: 2077-2080.PubMed Fossati P, Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982, 28: 2077-2080.PubMed
34.
go back to reference Izawa S, Okada M, Matsui H, Hotta Y, Hama H: A new direct method for measuring HDL-cholesterol which does not produce any biased values. Jpn J Med Pharm Sci. 1997, 37: 1385-1388. Izawa S, Okada M, Matsui H, Hotta Y, Hama H: A new direct method for measuring HDL-cholesterol which does not produce any biased values. Jpn J Med Pharm Sci. 1997, 37: 1385-1388.
35.
go back to reference Szasz G: Reaction-rate method for gamma-glutamyltransferase activity in serum. Clin Chem. 1976, 22: 2051-2055.PubMed Szasz G: Reaction-rate method for gamma-glutamyltransferase activity in serum. Clin Chem. 1976, 22: 2051-2055.PubMed
36.
go back to reference Bergmeyer HU, Horder M: International federation of clinical chemistry. Scientific committee. Expert panel on enzymes. IFCC document stage 2, draft 1; 1979-11-19 with a view to an IFCC recommendation. IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem. 1980, 18: 521-534.PubMed Bergmeyer HU, Horder M: International federation of clinical chemistry. Scientific committee. Expert panel on enzymes. IFCC document stage 2, draft 1; 1979-11-19 with a view to an IFCC recommendation. IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem. 1980, 18: 521-534.PubMed
37.
go back to reference Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H: Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007, 92: 3490-3497. 10.1210/jc.2007-0482.CrossRefPubMed Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H: Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007, 92: 3490-3497. 10.1210/jc.2007-0482.CrossRefPubMed
38.
go back to reference Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A: Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis. 2006, 186: 80-85. 10.1016/j.atherosclerosis.2005.07.012.CrossRefPubMed Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A: Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis. 2006, 186: 80-85. 10.1016/j.atherosclerosis.2005.07.012.CrossRefPubMed
39.
go back to reference Anderson ME, Allison RD, Meister A: Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. Proc Natl Acad Sci USA. 1982, 79: 1088-1091. 10.1073/pnas.79.4.1088.PubMedCentralCrossRefPubMed Anderson ME, Allison RD, Meister A: Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. Proc Natl Acad Sci USA. 1982, 79: 1088-1091. 10.1073/pnas.79.4.1088.PubMedCentralCrossRefPubMed
40.
go back to reference Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008, 28: 1039-1049. 10.1161/ATVBAHA.107.159228.CrossRefPubMed Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008, 28: 1039-1049. 10.1161/ATVBAHA.107.159228.CrossRefPubMed
41.
go back to reference Tenenbaum A, Fisman EZ, Motro M: Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovascular diabetology. 2003, 2: 4-10.1186/1475-2840-2-4.PubMedCentralCrossRefPubMed Tenenbaum A, Fisman EZ, Motro M: Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovascular diabetology. 2003, 2: 4-10.1186/1475-2840-2-4.PubMedCentralCrossRefPubMed
42.
go back to reference Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS: Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism. 2007, 56: 792-798. 10.1016/j.metabol.2007.01.010.CrossRefPubMed Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS: Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism. 2007, 56: 792-798. 10.1016/j.metabol.2007.01.010.CrossRefPubMed
Metadata
Title
The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome
Authors
Arie Steinvil
Itzhak Shapira
Orit Kliuk Ben-Bassat
Michael Cohen
Yaffa Vered
Shlomo Berliner
Ori Rogowski
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2010
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-9-30

Other articles of this Issue 1/2010

Cardiovascular Diabetology 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.